A phase 2, randomized, multi-center, double-blind, placebo-controlled, parallel-group, dose-range-finding study of the safety and efficacy of orally administered MD-0727 in patients with primary hypercholesterolemia
Phase of Trial: Phase II
Latest Information Update: 28 Sep 2007
At a glance
- Drugs MD 0727 (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- 03 Mar 2007 New trial record.